Catalia Health and Pfizer announced they have launched a pilot program to explore consumer behaviors outside of clinical environments. The pilot will test the affect that regular engagement with artificial intelligence (AI) has on a consumer’s treatment journey. The 12-month pilot uses the Mabu® Wellness Coach, a robot that uses AI to gather insights into symptom management and medication adherence trends in select consumers.
The Mabu robot can interact with individuals using AI algorithms to engage in tailored, voice-based conversations. Mabu “talks” with consumers about how they are feeling and helps answer questions they may have about their treatment. The Mabu Care Insights Platform then delivers detailed data and insights to clinicians at a specialty pharmacy provider organization to help human caregivers initiate timely and appropriate outreach to the consumer. The goal is to help better manage symptoms and address questions in real-time.
Mabu is helping to deliver personalized care by gaining insights that allow the specialty pharmacy to reach out to consumers as they express challenges in managing their conditions. Mabu also generates health tips and reminders to help consumers get additional information about their condition and treatment that may help them along the way. Over time, the goal is that Mabu can help consumers navigate barriers and health care challenges that are often a part of managing a chronic disease.
The pilot program was officially announced on stage at the National Association of Specialty Pharmacy’s Annual Meeting & Expo on September 10, 2019. Initial pilot data will be available in the coming months.
Catalia Health is a San Francisco-based care management company founded by Cory Kidd, Ph.D., in 2014. Catalia Health provides an effective and scalable solution for individuals managing chronic disease or taking medications on an ongoing basis. The company’s AI-powered robot, Mabu, enables health care provider organizations and pharmaceutical companies to better support persons living with chronic illness. Mabu uses a voice-based interface designed for simple, intuitive use by a wide variety of consumers in remote care environments. The cloud-based platform delivers unique conversations to consumers each time they have a conversation with Mabu.
Pfizer is a leading research-based biopharmaceutical company that applies science and global resources to deliver innovative therapies that extend and significantly improve lives. Pfizer makes medicines and vaccines that help people when they are sick and prevent them from getting sick in the first place, as well as some of the world’s best-known consumer health care brands. Pfizer’s colleagues work in developed and emerging markets to treat, cure, and eradicate life-threatening conditions and challenge some of the most feared diseases in our time. Pfizer also collaborates with health care provider organizations, governments, and local communities to support and expand access to reliable, affordable health care around the world.
This was reported by PR Newswire on September 12, 2019.
Contact information: Pfizer, Inc., 235 East 42nd Street, New York, New York 10017; 212-733-2323; Website: www.pfizer.com